6 11, 2018 Marzia del Re et. al, The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response Diatech Pharmacogenetics2018-11-06T14:24:10+01:00 Leggi di più
31 10, 2018 M Kursat Evrenos et. al, Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population Diatech Pharmacogenetics2018-12-04T14:23:43+01:00 Leggi di più
9 10, 2018 Simona Osella Abate et. al, ALK expression favorably impacts the prognosis of NRAS?mutated metastatic melanomas Diatech Pharmacogenetics2018-12-04T12:47:57+01:00 Leggi di più
1 10, 2018 Stefano Pizzolitto et. al, An unusual case of squamous cell carcinoma of the right colon Diatech Pharmacogenetics2018-12-04T12:34:29+01:00 Leggi di più
1 10, 2018 E. Leoni et.al, Universal screening to identify lynch syndrome: two years of experience Diatech Pharmacogenetics2018-12-04T12:14:58+01:00 Leggi di più
1 10, 2018 Duilio Della Libera et. al, Role of canonical and non canonical splicing mutation in patients with lynch syndrome Diatech Pharmacogenetics2018-10-01T11:24:06+02:00 Leggi di più
27 09, 2018 Roxas RBS et. al, Primary Thymic Signet Ring Cell Adenocarcinoma: A Currently Unrecognized Variant Diatech Pharmacogenetics2018-09-27T12:34:46+02:00 Leggi di più
20 08, 2018 Irene Baldi et. al, Rosai-Dorfman Disease Presenting As Peripheral Vascular Insufficiency Diatech Pharmacogenetics2018-08-27T14:13:58+02:00 Leggi di più
31 07, 2018 Imerio Angriman et. al, Effects of immune suppression for transplantation on inflammatory colorectal cancer progression Diatech Pharmacogenetics2018-08-27T12:58:50+02:00 Leggi di più
3 07, 2018 Federico Pessina et. al, Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment Diatech Pharmacogenetics2018-08-27T14:04:26+02:00 Leggi di più
